(8S,10S)-10-(((2R,4S,5R,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-8-(2-bromoacetyl)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; (8S-?cis)?-10-?[(3-?Amino-?2,?3,?6-?trideoxy-??-?L-?arabino-?hexopyranosyl)?oxy]?-?8-?(bromoacetyl)?-?7,?8,?9,?10-?tetrahydro-?6,?8,?11-?trihydroxy-?1-?methoxy-?5,?12-?naphthacenedione Hydrochloride
14-Bromo 4’-epi-Daunorubicin is a fully characterized chemical compound used as a reference standard of API Tetracycline. The standard offered is compliant with regulatory guidelines. 14-Bromo 4’-epi-Daunorubicin is used for analytical method development, method validation (AMV), and Quality Controlled (QC) applications during synthesis and formulation stages of drug development and serves as a reference standard for traceability against pharmacopeial standards (USP or EP). Axios Research products are intended for analytical purposes only and are not for human use. CAS - 99570-29-3
Related products
Epirubicin EP Impurity B (Daunorubicin EP Impurity A)
M.F.
M.W. 398.37
CAT# AR-T01738
CAS# 21794-55-8
